57 related articles for article (PubMed ID: 32761891)
1. Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial.
Cahill KN; Cui J; Kothari P; Murphy K; Raby BA; Singer J; Israel E; Boyce JA; Laidlaw TM
Am J Respir Crit Care Med; 2019 Sep; 200(6):704-711. PubMed ID: 30978291
[No Abstract] [Full Text] [Related]
2. Diet may be the common factor linking aspirin-exacerbated respiratory disease and atherosclerotic cardiovascular disease.
Miller JD
J Allergy Clin Immunol Pract; 2024 Feb; 12(2):539-540. PubMed ID: 38336404
[No Abstract] [Full Text] [Related]
3. During aspirin desensitization, omitting repeated provoking aspirin dose is safe.
D'Netto M; Sofola-James O; Sehanobish E; Divekar R; Jerschow E
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):955-957. PubMed ID: 36535521
[No Abstract] [Full Text] [Related]
4. Consequences of NSAID allergy on pain control options for patients with aspirin-exacerbated respiratory disease.
Bailey LB; Brown AN; Corcoran RC; Bensko JC; Buchheit KM; Laidlaw TM
J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1644-1646.e2. PubMed ID: 38423289
[No Abstract] [Full Text] [Related]
5. Long-term aspirin desensitization has mucosal cytokine features of immune tolerance.
Kohanski MA; Qatanani A; Lin C; Tan LH; Chang J; Corr A; Herzberg S; Adappa ND; Palmer JN; Reed DR; Bosso JV; Cohen NA
Allergy; 2024 Feb; 79(2):507-509. PubMed ID: 37727998
[No Abstract] [Full Text] [Related]
6. Characterization of alcohol-induced respiratory symptoms in aspirin-exacerbated respiratory disease.
Ramos CL; Thakrar H; Walters K; Waldram J; White AA
Ann Allergy Asthma Immunol; 2023 Sep; 131(3):382-384. PubMed ID: 37302527
[No Abstract] [Full Text] [Related]
7. Efficacy of various dosing frequencies of dupilumab in patients with aspirin-exacerbated respiratory disease.
Brown AN; Laidlaw TM; Buchheit KM; Bensko JC; Corcoran RC; Bailey LB
J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1647-1648. PubMed ID: 38484871
[No Abstract] [Full Text] [Related]
8. Aspirin-Exacerbated Respiratory Disease.
Kuhn DM
N Engl J Med; 2018 Dec; 379(23):2281. PubMed ID: 30592398
[No Abstract] [Full Text] [Related]
9. Aspirin-Exacerbated Respiratory Disease.
White AA; Stevenson DD
N Engl J Med; 2018 Dec; 379(23):2281-2282. PubMed ID: 30575459
[No Abstract] [Full Text] [Related]
10. Dupilumab improves alcohol tolerance in aspirin-exacerbated respiratory disease.
Arnold M; Kuruvilla M; Levy JM; Xu J
Ann Allergy Asthma Immunol; 2021 Sep; 127(3):379-381. PubMed ID: 34004275
[No Abstract] [Full Text] [Related]
11. Reply to "Diet may be the common factor linking aspirin-exacerbated respiratory disease and atherosclerotic cardiovascular disease".
Adame MJ; Raji M; Shan Y; Zhang Y; Kuo YF; Tripple JW
J Allergy Clin Immunol Pract; 2024 Feb; 12(2):540-541. PubMed ID: 38336405
[No Abstract] [Full Text] [Related]
12. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
Macy E; Bernstein JA; Castells MC; Gawchik SM; Lee TH; Settipane RA; Simon RA; Wald J; Woessner KM;
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):172-4. PubMed ID: 17304886
[TBL] [Abstract][Full Text] [Related]
13. Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
Buchheit KM; Hacker J; Maurer R; McGill A; Ryan T; Bensko JC; Laidlaw TM
Clin Exp Allergy; 2023 Sep; 53(9):974-977. PubMed ID: 37246613
[No Abstract] [Full Text] [Related]
14. Immunologic effects of aspirin desensitization and high-dose aspirin therapy in aspirin-exacerbated respiratory disease.
Cahill KN
J Allergy Clin Immunol; 2021 Aug; 148(2):344-347. PubMed ID: 34144108
[No Abstract] [Full Text] [Related]
15. Aspirin-Exacerbated Respiratory Disease.
White AA; Stevenson DD
N Engl J Med; 2018 Sep; 379(11):1060-1070. PubMed ID: 30207919
[No Abstract] [Full Text] [Related]
16. Current complications and treatment of aspirin-exacerbated respiratory disease.
Cook KA; Stevenson DD
Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
[TBL] [Abstract][Full Text] [Related]
17. Age as a factor in treatment of aspirin-exacerbated respiratory disease: relationship to required aspirin maintenance dose after desensitization.
Locke TB; Sweis AM; Gleeson PK; Lin TC; Civantos AM; Parhar HS; Corr AM; Kumar A; Salmon MK; Kohanski MA; Palmer JN; Bosso JV; Adappa ND
Int Forum Allergy Rhinol; 2020 Oct; 10(10):1180-1181. PubMed ID: 32761891
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
